This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
BTG Limited
BTG Limited, a prominent player in the healthcare industry, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 1991, the company has established itself as a leader in the development of innovative medical technologies, particularly in the fields of interventional medicine and pharmaceuticals. Specialising in products that enhance patient outcomes, BTG Limited offers a range of unique services, including targeted therapies for cancer and advanced solutions for vascular conditions. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in the medical community. With a strong market presence and a reputation for excellence, BTG Limited continues to drive advancements in healthcare, making a meaningful impact on patient care worldwide.
DitchCarbon Score
How does BTG Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BTG Limited's score of 97 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BTG Limited, headquartered in Great Britain, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Boston Scientific Corporation, which cascades its emissions data and climate commitments down to BTG Limited. As part of its corporate family relationship, BTG Limited adheres to the climate initiatives and targets set by Boston Scientific Corporation. However, specific reduction targets or achievements for BTG Limited are not detailed in the available information. Boston Scientific Corporation has established various climate commitments, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which guide its subsidiaries in setting and achieving meaningful emissions reduction goals. While BTG Limited does not report its own emissions figures, it is aligned with the broader sustainability efforts of its parent company, focusing on reducing its carbon footprint and contributing to climate action within the medical technology industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BTG Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
